With assistance from the Center for Technology Commercialization (CTC), Tasso, Inc., located in downtown Madison, recently received $2.3 million in federal funding for commercialization. The medical device company develops HemoLink™, a pain-free and convenient method to acquire blood samples from patients.
Dr. Erwin Berthier, Dr. Ben Casavant and Ben Moga developed the technology while they were biomedical engineering students at the University of Wisconsin-Madison. They noticed that while blood sample analysis techniques had dramatically improved the ability to diagnose and treat diseases, the method to collect samples had not changed in decades. They created HemoLink in response to this lag in technology.
To use the device, a patch is applied to the patient’s shoulder, which painlessly draws blood from the skin in about two minutes. The patient then removes the patch and mails it to the lab. The product leverages existing resources to expand the reach of health care and revolutionize blood test methods.
With HemoLink, patients are able to get results without having to go a clinic, and doctors can identify issues before they become major health emergencies. The team hopes this funding will help make the medical device available to all patients, especially those who depend on frequent analysis of their blood to remain healthy.
Backed by knowledge and connections gained from CTC staff, the Wisconsin Entrepreneurial Bootcamp at UW-Madison, and conversations with many experts and mentors, Tasso is now working to develop relationships with larger corporate partners, including diagnostic companies and distributors.
To learn more about Tasso medical devices, visit TassoInc.com.